Ainos Inc (AIMD)

$3.29 +0.10 (3.13%)
Market Cap 13.79M
Revenue (ttm) 20,000.00
Net Income (ttm) -14.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -74,300.00%
Debt to Equity Ratio 0.08
Volume 59,900
Avg Vol 65,958
Day's Range N/A - N/A
Shares Out 4.19M
Stochastic %K 94%
Beta 2.13
Analysts Strong Buy
Price Target N/A

Company Profile

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal h...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 869 2986
Address:
8880 Rio San Diego Drive, Suite 800, San Diego, United States
SilverTongue
SilverTongue Jul. 7 at 3:00 PM
$AIMD
0 · Reply
SilverTongue
SilverTongue Jul. 7 at 12:02 PM
$AIMD https://feeds.issuerdirect.com/news-release.html?newsid=6916732681042351&symbol=AIMD
0 · Reply
SilverTongue
SilverTongue Jul. 6 at 12:51 PM
$AIMD
0 · Reply
TechFan6
TechFan6 Jul. 3 at 5:44 PM
$AIMD After major wins in 1H 2025, Ainos is entering a high-impact commercial phase in 2H 2025. Worth keeping an eye on as the Smell Language Model (SLM) continues evolving as a potential foundational model for scent-based AI.
0 · Reply
SilverTongue
SilverTongue Jul. 3 at 4:48 PM
$AIMD Last two days not much volume. Imagine when the volume is there
0 · Reply
dillydally1
dillydally1 Jul. 3 at 3:33 PM
$AIMD just wait until we get an update on the factory pilots
1 · Reply
TechFan6
TechFan6 Jul. 3 at 3:25 PM
$AIMD AIMD is on the rise again today 📈 AI Nose is delivering on real-world impact—using its smell language model (#SLM) to teach machines how to smell. Ainos is turning SmellTech from science fiction into sensory infrastructure.
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jul. 3 at 2:32 PM
$AIMD Heavy reversal
0 · Reply
Quloricon
Quloricon Jul. 3 at 11:27 AM
$AIMD Momentum should arrive soon.
0 · Reply
SilverTongue
SilverTongue Jul. 3 at 10:59 AM
$AIMD
0 · Reply
Latest News on AIMD
Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape

Jul 7, 2025, 8:00 AM EDT - 3 hours ago

Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape

Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization

Jun 30, 2025, 8:00 AM EDT - 7 days ago

Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization

Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites

Jun 27, 2025, 8:00 AM EDT - 10 days ago

Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites

ASX

Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation

Jun 26, 2025, 11:00 AM EDT - 11 days ago

Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation

Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia

Jun 24, 2025, 8:00 AM EDT - 13 days ago

Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia

Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25

Jun 17, 2025, 11:35 AM EDT - 20 days ago

Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25

Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy

Jun 16, 2025, 8:00 AM EDT - 21 days ago

Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy

Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter

Jun 3, 2025, 8:00 AM EDT - 4 weeks ago

Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter

Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%

May 29, 2025, 8:00 AM EDT - 5 weeks ago

Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%

Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner

May 22, 2025, 8:00 AM EDT - 6 weeks ago

Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner

Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy

May 19, 2025, 8:00 AM EDT - 7 weeks ago

Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

May 14, 2025, 8:00 AM EDT - 7 weeks ago

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

Ainos Reports First Quarter 2025 Financial Results

May 12, 2025, 8:00 AM EDT - 2 months ago

Ainos Reports First Quarter 2025 Financial Results

Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

Apr 30, 2025, 8:12 AM EDT - 2 months ago

Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

ASX

Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly

Apr 23, 2025, 8:00 AM EDT - 2 months ago

Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly

Ainos and ugo Complete First Robotic Smell Integration in Japan

Apr 21, 2025, 8:00 AM EDT - 2 months ago

Ainos and ugo Complete First Robotic Smell Integration in Japan

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

Apr 14, 2025, 8:00 AM EDT - 3 months ago

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling

Apr 11, 2025, 8:00 AM EDT - 3 months ago

Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling

Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025

Mar 24, 2025, 5:00 PM EDT - 3 months ago

Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025

Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose's Potential in Chip Manufacturing and More

Mar 13, 2025, 9:00 AM EDT - 4 months ago

Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose's Potential in Chip Manufacturing and More

ASX

Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing

Mar 11, 2025, 9:00 AM EDT - 4 months ago

Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing

ASX

Ainos Reports Full Year 2024 Financial Results

Mar 7, 2025, 4:45 PM EST - 4 months ago

Ainos Reports Full Year 2024 Financial Results

Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

Mar 7, 2025, 1:30 PM EST - 4 months ago

Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

Ainos and ugo to Develop the World's First Robot With a Sense of Smell

Mar 5, 2025, 10:00 AM EST - 4 months ago

Ainos and ugo to Develop the World's First Robot With a Sense of Smell

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

Jan 27, 2025, 10:00 AM EST - 5 months ago

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

Jan 21, 2025, 10:00 AM EST - 5 months ago

Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

Jan 17, 2025, 9:00 AM EST - 6 months ago

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots

Jan 13, 2025, 10:00 AM EST - 6 months ago

Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Dec 18, 2024, 12:05 PM EST - 7 months ago

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Dec 18, 2024, 8:00 AM EST - 7 months ago

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

Dec 13, 2024, 8:00 AM EST - 7 months ago

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

Dec 4, 2024, 8:00 AM EST - 7 months ago

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

Dec 2, 2024, 8:00 AM EST - 7 months ago

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

Nov 13, 2024, 8:00 AM EST - 8 months ago

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Nov 11, 2024, 8:00 AM EST - 8 months ago

Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

Nov 8, 2024, 8:00 AM EST - 8 months ago

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

Ainos Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:30 PM EST - 8 months ago

Ainos Reports Third Quarter 2024 Financial Results

Ainos Expands Patent Portfolio With Strategic Shareholder's Cutting-Edge Technology Assets

Oct 28, 2024, 8:00 AM EDT - 9 months ago

Ainos Expands Patent Portfolio With Strategic Shareholder's Cutting-Edge Technology Assets

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

Oct 24, 2024, 10:50 AM EDT - 9 months ago

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies

Oct 7, 2024, 8:00 AM EDT - 9 months ago

Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA

Sep 25, 2024, 8:00 AM EDT - 10 months ago

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA

Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren's Syndrome

Sep 24, 2024, 10:55 AM EDT - 10 months ago

Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren's Syndrome

Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options

Sep 23, 2024, 8:00 AM EDT - 10 months ago

Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

Sep 20, 2024, 8:00 AM EDT - 10 months ago

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

Sep 17, 2024, 8:00 AM EDT - 10 months ago

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention

Sep 3, 2024, 8:30 AM EDT - 10 months ago

Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention

Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 8:30 AM EDT - 11 months ago

Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter

Aug 26, 2024, 8:30 AM EDT - 11 months ago

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter

Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety

Aug 19, 2024, 9:15 AM EDT - 11 months ago

Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety

Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024

Aug 12, 2024, 8:00 AM EDT - 11 months ago

Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024

SilverTongue
SilverTongue Jul. 7 at 3:00 PM
$AIMD
0 · Reply
SilverTongue
SilverTongue Jul. 7 at 12:02 PM
$AIMD https://feeds.issuerdirect.com/news-release.html?newsid=6916732681042351&symbol=AIMD
0 · Reply
SilverTongue
SilverTongue Jul. 6 at 12:51 PM
$AIMD
0 · Reply
TechFan6
TechFan6 Jul. 3 at 5:44 PM
$AIMD After major wins in 1H 2025, Ainos is entering a high-impact commercial phase in 2H 2025. Worth keeping an eye on as the Smell Language Model (SLM) continues evolving as a potential foundational model for scent-based AI.
0 · Reply
SilverTongue
SilverTongue Jul. 3 at 4:48 PM
$AIMD Last two days not much volume. Imagine when the volume is there
0 · Reply
dillydally1
dillydally1 Jul. 3 at 3:33 PM
$AIMD just wait until we get an update on the factory pilots
1 · Reply
TechFan6
TechFan6 Jul. 3 at 3:25 PM
$AIMD AIMD is on the rise again today 📈 AI Nose is delivering on real-world impact—using its smell language model (#SLM) to teach machines how to smell. Ainos is turning SmellTech from science fiction into sensory infrastructure.
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jul. 3 at 2:32 PM
$AIMD Heavy reversal
0 · Reply
Quloricon
Quloricon Jul. 3 at 11:27 AM
$AIMD Momentum should arrive soon.
0 · Reply
SilverTongue
SilverTongue Jul. 3 at 10:59 AM
$AIMD
0 · Reply
TechFan6
TechFan6 Jul. 2 at 6:57 PM
$AIMD AI Nose, powered by its Smell Language Model (#SLM), is creating AI’s next token: scent. It now classifies food and drink odors with over 90% accuracy and detects hygiene issues in senior care settings with over 85% accuracy across 2,000+ samples. Applications span healthcare, environmental monitoring, cleanroom processes, and smart factories—bringing machines one step closer to truly understanding the world through smell. Also, $AIMD stock is up today 📈—momentum building as innovation hits the market!
0 · Reply
TechFan6
TechFan6 Jul. 2 at 6:07 PM
$AIMD AIMD gives robots the ability to smell. Pilot deployments with ASE could scale from 1,400 to 15,000 AI Nose units—real traction, not hype. Smell is becoming the next frontier in machine perception!
0 · Reply
Thebullrun
Thebullrun Jul. 2 at 5:17 PM
$AIMD amazing this was .50 a few weeks back!! Crazy tech!! Let’s rock!!
1 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jul. 2 at 5:00 PM
$AIMD
0 · Reply
CupShaker
CupShaker Jul. 2 at 4:43 PM
$AVAX.X $AIMD $BBAI
0 · Reply
SilverTongue
SilverTongue Jul. 2 at 4:38 PM
$AIMD
0 · Reply
Thebullrun
Thebullrun Jul. 2 at 4:33 PM
$AIMD you’re welcome all who go it at .50? ;) let’s rock!!
1 · Reply
TechFan6
TechFan6 Jul. 2 at 4:29 PM
$AIMD AI Nose, powered by its Smell Language Model (#SLM), is creating AI's next token: scent. It now classifies food and drink odors with over 90% accuracy—bringing machines one step closer to truly understanding the world through smell! https://x.com/AIFan249314/status/1940446677917122690
0 · Reply
dillydally1
dillydally1 Jul. 2 at 4:25 PM
$AIMD glad I bought some at 2.65 Wanted more but it’s not coming down!
0 · Reply
CulinaryCapitalist
CulinaryCapitalist Jul. 2 at 3:18 PM
$AIMD lets gooo
0 · Reply
Thebullrun
Thebullrun Jul. 2 at 3:05 PM
$AIMD #AIMD #NASDAQ Ainos, Inc. (NASDAQ: AIMD) Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization. Great Success! https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ainos-completes-stock-consolidation-enters-new-phase-of-global-expans-1044229
0 · Reply
Tunes444
Tunes444 Jul. 2 at 1:36 PM
$AIMD
0 · Reply